your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Enalapril improves outcome in asymptomatic LV dysfunction
Enalapril improves outcome in asymptomatic LV dysfunction
In the SOLVD prevention trial of 4228 patients (83 percent post-MI) with asymptomatic left ventricular dysfunction, prophylactic administration of enalapril reduced the probability of death or heart failure (p<0.001).
ACE: angiotensin-converting enzyme; LV: left ventricular; MI: myocardial infarction.
Data from: The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685.
